Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2023-10-25 Option Award |
2023-10-27 4:14 pm |
2023-10-25 2030-10-25 |
Aligos Therapeutics Inc. | ALGS | BLATT LAWRENCE Chief Executive Officer |
305,138 | $0.125 | 2,425,771 (Direct) |
View |
| 2023-10-25 Option Award |
2023-10-27 4:14 pm |
N/A N/A |
Aligos Therapeutics Inc. | ALGS | BLATT LAWRENCE Chief Executive Officer |
610,277 | $0.7568 | 2,425,771 (Direct) |
View |
| 2023-10-25 Option Award |
2023-10-27 4:13 pm |
2023-10-25 2030-10-25 |
Aligos Therapeutics Inc. | ALGS | Scopa James Paul Director |
91,541 | $0.125 | 274,624 (Direct) |
View |
| 2023-10-25 Option Award |
2023-10-27 4:13 pm |
N/A N/A |
Aligos Therapeutics Inc. | ALGS | Scopa James Paul Director |
183,083 | $0.7568 | 274,624 (Direct) |
View |
| 2023-09-08 Option Award |
2023-09-12 4:08 pm |
N/A 2033-09-08 |
Aligos Therapeutics Inc. | ALGS | McClure Matthew W. Chief Medical Officer |
48,000 | $0 | 48,000 (Direct) |
View |
| 2023-09-08 Option Award |
2023-09-12 4:07 pm |
N/A 2033-09-08 |
Aligos Therapeutics Inc. | ALGS | Calhoun Lesley Ann See Remarks |
48,000 | $0 | 48,000 (Direct) |
View |
| 2023-09-08 Option Award |
2023-09-12 4:07 pm |
N/A 2033-09-08 |
Aligos Therapeutics Inc. | ALGS | Quan Lucinda Y. See Remarks |
48,000 | $0 | 48,000 (Direct) |
View |
| 2023-09-08 Option Award |
2023-09-12 4:06 pm |
N/A 2033-09-08 |
Aligos Therapeutics Inc. | ALGS | Symons Julian A. See Remarks |
48,000 | $0 | 48,000 (Direct) |
View |
| 2023-09-08 Option Award |
2023-09-12 4:05 pm |
N/A 2033-09-08 |
Aligos Therapeutics Inc. | ALGS | BLATT LAWRENCE Chief Executive Officer |
150,000 | $0 | 150,000 (Direct) |
View |
| 2023-07-20 Option Award |
2023-07-21 9:06 pm |
N/A 2033-07-20 |
Aligos Therapeutics Inc. | ALGS | Martell Bridget A Director |
20,000 | $0 | 20,000 (Direct) |
View |
| 2023-07-20 Option Award |
2023-07-21 7:23 pm |
N/A 2033-07-20 |
Aligos Therapeutics Inc. | ALGS | Nielsen Jack Director |
20,000 | $0 | 20,000 (Direct) |
View |
| 2023-07-20 Option Award |
2023-07-21 4:13 pm |
N/A 2033-07-20 |
Aligos Therapeutics Inc. | ALGS | Hirth Peter Director |
20,000 | $0 | 20,000 (Direct) |
View |
| 2023-07-20 Option Award |
2023-07-21 4:11 pm |
N/A 2033-07-20 |
Aligos Therapeutics Inc. | ALGS | Scopa James Paul Director |
20,000 | $0 | 20,000 (Direct) |
View |
| 2023-07-20 Option Award |
2023-07-21 4:10 pm |
N/A 2033-07-20 |
Aligos Therapeutics Inc. | ALGS | Nuechterlein Carole Director |
20,000 | $0 | 20,000 (Direct) |
View |
| 2023-03-15 Option Award |
2023-03-17 4:12 pm |
N/A 2033-03-15 |
Aligos Therapeutics Inc. | ALGS | McClure Matthew W. Chief Medical Officer |
75,000 | $0 | 75,000 (Direct) |
View |
| 2023-03-15 Option Award |
2023-03-17 4:11 pm |
N/A 2033-03-15 |
Aligos Therapeutics Inc. | ALGS | Symons Julian A. See Remarks |
78,750 | $0 | 78,750 (Direct) |
View |
| 2023-03-15 Option Award |
2023-03-17 4:11 pm |
N/A 2033-03-15 |
Aligos Therapeutics Inc. | ALGS | Calhoun Lesley Ann See Remarks |
78,750 | $0 | 78,750 (Direct) |
View |
| 2023-03-15 Option Award |
2023-03-17 4:10 pm |
N/A 2033-03-15 |
Aligos Therapeutics Inc. | ALGS | Quan Lucinda Y. See Remarks |
78,750 | $0 | 78,750 (Direct) |
View |
| 2023-03-15 Option Award |
2023-03-17 4:10 pm |
N/A 2033-03-15 |
Aligos Therapeutics Inc. | ALGS | Beigelman Leonid President |
169,500 | $0 | 169,500 (Direct) |
View |
| 2023-03-15 Option Award |
2023-03-17 4:09 pm |
N/A 2033-03-15 |
Aligos Therapeutics Inc. | ALGS | BLATT LAWRENCE Chief Executive Officer |
242,500 | $0 | 242,500 (Direct) |
View |
| 2022-07-07 Option Award |
2022-07-11 4:15 pm |
N/A 2032-07-07 |
Aligos Therapeutics Inc. | ALGS | McClure Matthew W. Chief Medical Officer |
46,000 | $0 | 46,000 (Direct) |
View |
| 2022-07-07 Option Award |
2022-07-11 4:15 pm |
N/A 2032-07-07 |
Aligos Therapeutics Inc. | ALGS | Quan Lucinda Y. See Remarks |
52,500 | $0 | 52,500 (Direct) |
View |
| 2022-07-07 Option Award |
2022-07-11 4:14 pm |
N/A 2032-07-07 |
Aligos Therapeutics Inc. | ALGS | Calhoun Lesley Ann See Remarks |
52,500 | $0 | 52,500 (Direct) |
View |
| 2022-07-07 Option Award |
2022-07-11 4:13 pm |
N/A 2032-07-07 |
Aligos Therapeutics Inc. | ALGS | Beigelman Leonid President |
113,000 | $0 | 113,000 (Direct) |
View |
| 2022-07-07 Option Award |
2022-07-11 4:13 pm |
N/A 2032-07-07 |
Aligos Therapeutics Inc. | ALGS | BLATT LAWRENCE Chief Executive Officer |
161,700 | $0 | 161,700 (Direct) |
View |
| 2022-07-07 Option Award |
2022-07-11 4:12 pm |
N/A 2032-07-07 |
Aligos Therapeutics Inc. | ALGS | Symons Julian A. See Remarks |
50,000 | $0 | 50,000 (Direct) |
View |
| 2022-06-23 Option Award |
2022-06-27 4:14 pm |
N/A 2032-06-23 |
Aligos Therapeutics Inc. | ALGS | Woiwode Thomas Director |
15,000 | $0 | 15,000 (Direct) |
View |
| 2022-06-23 Option Award |
2022-06-27 4:14 pm |
N/A 2032-06-23 |
Aligos Therapeutics Inc. | ALGS | Hirth Peter Director |
15,000 | $0 | 15,000 (Direct) |
View |
| 2022-06-23 Option Award |
2022-06-27 4:13 pm |
N/A 2032-06-23 |
Aligos Therapeutics Inc. | ALGS | Scopa James Paul Director |
15,000 | $0 | 15,000 (Direct) |
View |
| 2022-06-23 Option Award |
2022-06-27 4:13 pm |
N/A 2032-06-23 |
Aligos Therapeutics Inc. | ALGS | Nielsen Jack Director |
15,000 | $0 | 15,000 (Direct) |
View |
| 2022-06-23 Option Award |
2022-06-27 4:12 pm |
N/A 2032-06-23 |
Aligos Therapeutics Inc. | ALGS | Nuechterlein Carole Director |
15,000 | $0 | 15,000 (Direct) |
View |
| 2022-06-23 Option Award |
2022-06-27 4:11 pm |
N/A 2032-06-23 |
Aligos Therapeutics Inc. | ALGS | Martell Bridget A Director |
15,000 | $0 | 15,000 (Direct) |
View |
Ownership |
2022-05-06 4:12 pm |
N/A N/A |
Aligos Therapeutics Inc. | ALGS | McClure Matthew W. Chief Medical Officer |
0 | $0 | 515,478 (Indirect) |
View |
| 2022-02-04 Option Award |
2022-02-08 4:09 pm |
N/A 2032-02-04 |
Aligos Therapeutics Inc. | ALGS | Symons Julian A. See Remarks |
131,250 | $0 | 131,250 (Direct) |
View |
| 2022-02-04 Option Award |
2022-02-08 4:09 pm |
N/A 2032-02-04 |
Aligos Therapeutics Inc. | ALGS | BLATT LAWRENCE Chief Executive Officer |
404,250 | $0 | 404,250 (Direct) |
View |
| 2022-02-04 Option Award |
2022-02-08 4:08 pm |
N/A 2032-02-04 |
Aligos Therapeutics Inc. | ALGS | Calhoun Lesley Ann See Remarks |
131,250 | $0 | 131,250 (Direct) |
View |
| 2022-02-04 Option Award |
2022-02-08 4:07 pm |
N/A 2032-02-04 |
Aligos Therapeutics Inc. | ALGS | Quan Lucinda Y. See Remarks |
131,250 | $0 | 131,250 (Direct) |
View |
| 2022-02-04 Option Award |
2022-02-08 4:07 pm |
N/A 2032-02-04 |
Aligos Therapeutics Inc. | ALGS | Beigelman Leonid President |
283,500 | $0 | 283,500 (Direct) |
View |
| 2021-11-16 Option Award |
2021-11-18 4:38 pm |
N/A 2031-11-16 |
Aligos Therapeutics Inc. | ALGS | Martell Bridget A Director |
30,000 | $0 | 30,000 (Direct) |
View |
| 2021-06-17 Option Award |
2021-06-17 6:46 pm |
N/A 2031-06-17 |
Aligos Therapeutics Inc. | ALGS | Nielsen Jack Director |
15,000 | $0 | 15,000 (Direct) |
View |
| 2021-06-17 Option Award |
2021-06-17 5:14 pm |
N/A 2031-06-17 |
Aligos Therapeutics Inc. | ALGS | Woiwode Thomas Director |
15,000 | $0 | 15,000 (Direct) |
View |